Page 17 - Sight Sciences News Today

SGHT earnings call for the period ending March 31, 2022.

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

A coalition of travel and business groups is urging the Biden administration to nudge the federal workforce back into their offices.

Sight Sciences, Inc. (NASDAQ:SGHT – Get Rating)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $11.67, but opened at $11.93. Sight Sciences shares last traded at $11.68, with a volume of 6,993 shares trading hands. A number of equities research analysts have commented on the company. Citigroup […]

Nemaura Medical (NASDAQ:NMRD – Get Rating) and Sight Sciences (NASDAQ:SGHT – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, institutional ownership, earnings, risk and profitability. Analyst Recommendations This is a breakdown of current ratings […]

Sight Sciences (NASDAQ:SGHT – Get Rating) announced its earnings results on Thursday. The company reported ($0.34) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.39) by $0.05, Fidelity Earnings reports. Sight Sciences updated its FY 2022 guidance to EPS. Shares of SGHT opened at $13.46 on Friday. The company has a debt-to-equity […]

SGHT earnings call for the period ending December 31, 2021.

Sight Sciences Reports Fourth Quarter and Full Year 2021 Financial Results MENLO PARK, Calif., March 24, 2022 -- Sight Sciences, Inc. , an eyecare technology company focused on... | March 24, 2022

Sight Sciences Inc (NASDAQ:SGHT – Get Rating) fell 3.7% during mid-day trading on Monday . The stock traded as low as $14.73 and last traded at $14.73. 5 shares were traded during trading, a decline of 100% from the average session volume of 300,513 shares. The stock had previously closed at $15.29. Several research firms […]

Biopharma and life sciences companies continue to strengthen their executive teams and boards with this week’s Movers & Shakers.